Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1993]
News [3240]
Articles [134]
Editorials [3]
Conferences [122]
elearning [18]
Acute myeloid leukaemia (AML) at EHA 2013
Prof Gert Ossenkoppele - VU University Medical Center, The Netherlands
Acute myeloid leukaemia (AML) at EHA 2013 ( Prof Gert Ossenkoppele - VU University Medical Center, The Netherlands )
25 Jun 2013
The future management of mantle cell lymphoma
Dr Simon Rule - Derriford Hospital, Plymouth, UK and Dr Martin Dreyling...
The future management of mantle cell lymphoma ( Dr Simon Rule - Derriford Hospital, Plymouth, UK and Dr Martin Dreyling - Ludwig Maximilians-University, Munich, Germany )
25 Jun 2013
Relapsed or progressive multiple myeloma
Dr Ruben Niesvizky - Weill Cornell Medical College, New York, USA
Relapsed or progressive multiple myeloma ( Dr Ruben Niesvizky - Weill Cornell Medical College, New York, USA )
20 Jun 2013
Pomalidomide prolongs survival in refractory multiple myeloma patients
Prof Jesus San Miguel - University Hospital of Salamanca, Salamanca, Spain
Pomalidomide prolongs survival in refractory multiple myeloma patients ( Prof Jesus San Miguel - University Hospital of Salamanca, Salamanca, Spain )
19 Jun 2013
Carfilzomib plus melphalanprednisone in elderly patients with newly diagnosed...
Prof Philippe Moreau - Centre Hospitalier Universitaire de Nantes, France
Carfilzomib plus melphalanprednisone in elderly patients with newly diagnosed multiple myeloma ( Prof Philippe Moreau - Centre Hospitalier Universitaire de Nantes, France )
19 Jun 2013
Age and ageing in blood disorders
Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands
Age and ageing in blood disorders ( Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands )
19 Jun 2013
Rituximab for b-cell lymphoma and EHA overview
Prof Ulrich Jäger - EHA President and Vienna Medical University, Austria
Rituximab for b-cell lymphoma and EHA overview ( Prof Ulrich Jäger - EHA President and Vienna Medical University, Austria )
19 Jun 2013
Highlights from EHA 2013
Prof Anton Hagenbeek - Universitair Medisch Centrum Utrecht, Heidelberglaan...
Highlights from EHA 2013 ( Prof Anton Hagenbeek - Universitair Medisch Centrum Utrecht, Heidelberglaan, Netherlands )
19 Jun 2013
Patient advocacy track 'personalised medicine'
Prof Anton Hagenbeek - Universitair Medisch Centrum Utrecht, Heidelberglaan...
Patient advocacy track 'personalised medicine' ( Prof Anton Hagenbeek - Universitair Medisch Centrum Utrecht, Heidelberglaan, Netherlands )
19 Jun 2013
Second line treatment of multiple myeloma with melphalan prednisone and...
Prof Meletios Dimopoulos - Univeristy of Athens, Greece
Second line treatment of multiple myeloma with melphalan prednisone and lenalidomide ( Prof Meletios Dimopoulos - Univeristy of Athens, Greece )
19 Jun 2013
Challenges facing haematologists treating acute myeloid leukaemia
Dr Dalia Mahmoud - Celgene Corporation, Summit, USA
Challenges facing haematologists treating acute myeloid leukaemia ( Dr Dalia Mahmoud - Celgene Corporation, Summit, USA )
19 Jun 2013
JAK-STAT pathway in malignant and non-malignant cells in myeloproliferative...
Dr Ross Levine - Memorial Sloan-Kettering Cancer Center, New York, USA
JAK-STAT pathway in malignant and non-malignant cells in myeloproliferative neoplasms ( Dr Ross Levine - Memorial Sloan-Kettering Cancer Center, New York, USA )
19 Jun 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation